• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Molecular Biometrics

edit

Molecular Biometrics, Inc., is applying novel metabolomic technologies to develop accurate, non-invasive methodologies for evaluating normal biologic function in health and disease, and for drug discovery and development. The company’s proprietary technology is being applied in reproductive health, neurodegenerative disease (Alzheimer’s disease and Parkinson’s disease), maternal fetal medicine, pulmonary metabolism and edema, and lactate metabolism.

Milestones

edit

• 
  Molecular Biometrics added Frank E. Thomas as CFO.
  Posted 1/12/10 at 6:52pm
• 
  Molecular Biometrics added Bruce Goldstein as Vice President, Operations.
  Posted 1/12/10 at 6:52pm
• 
  Molecular Biometrics added James T. Posillico as President & CEO.
  Posted 1/12/10 at 6:52pm
• 
  Molecular Biometrics received $12.5M in Series B funding. (1/12/10)
  Posted 1/12/10 at 6:52pm via finsmes.com

Videos

Screenshots

edit

Above: Home Page
Uploaded: 1/13/10

Sources

1. Molecular Biometrics Closes $12.5M Series B Equity Funding (finsmes.com) [edit]